Table of Content

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments

1.3.1. List of Key Players Profiled In The Report

1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study
2.2. Key Findings

2.2.1. Top Investment Pockets
2.2.2. Top Player Positioning, 2018

2.3. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Key Forces Shaping Premenstrual Syndrome Treatment Industry/Market

3.2.1. Moderate Power of Suppliers
3.2.2. Moderate Threat of New Entrants
3.2.3. Low Threat of Substitution
3.2.4. Moderate Competitive Rivalry
3.2.5. Moderate Bargaining Power of Buyers

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Increase In Prevalence of Pms
3.3.1.2. Growth In Awareness For Pms Therapeutics
3.3.1.3. Surge In Healthcare Expenditure Worldwide

3.3.2. Restraint

3.3.2.1. Poor Demand In Under Developed Countries

3.3.3. Opportunities

3.3.3.1. Growth Opportunities In Emerging Markets
3.3.3.2. Higher Number of Unmet Needs For Treatment of Pms

3.3.4. Impact Analysis

Chapter 4: Premenstrual Syndrome Treatment Market, By Drug Type

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Analgesics

4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country

4.3. Antidepressants

4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country

4.4. Oral Contraceptives & Ovarian Suppression Agents

4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country

4.5. Others

4.5.1. Key Market Trends And Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis, By Country

Chapter 5: Premenstrual Syndrome Treatment Market, By Type.

5.1. Overview

5.1.1. Market Size And Forecast

5.2. Prescription

5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country

5.3. Otc

5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country

Chapter 6: Premenstrual Syndrome Treatment Market, By Distribution Channel

6.1. Overview

6.1.1. Market Size And Forecast

6.2. Hospitals Pharmacies

6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country

6.3. Drug Stores & Retail Pharmacies

6.3.1. Market Size And Forecast
6.3.2. Market Analysis, By Country

6.4. Online Pharmacies

6.4.1. Market Size And Forecast
6.4.2. Market Analysis, By Country

Chapter 7: Premenstrual Syndrome Treatment Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country

7.2.2.1. U.S.

7.2.2.1.1. U.S. Premenstrual Syndrome Treatment Market, By Drug Type
7.2.2.1.2. U.S. Premenstrual Syndrome Treatment Market, By Type
7.2.2.1.3. U.S. Premenstrual Syndrome Treatment Market, By Distribution Channel

7.2.2.2. Canada

7.2.2.2.1. Canada Premenstrual Syndrome Treatment Market, By Drug Type
7.2.2.2.2. Canada Premenstrual Syndrome Treatment Market, By Type
7.2.2.2.3. Canada Premenstrual Syndrome Treatment Market, By Distribution Channel

7.2.2.3. Mexico

7.2.2.3.1. Mexico Premenstrual Syndrome Treatment Market, By Drug Type
7.2.2.3.2. Mexico Premenstrual Syndrome Treatment Market, By Type
7.2.2.3.3. Mexico Premenstrual Syndrome Treatment Market, By Distribution Channel

7.2.3. North America Market Size And Forecast, By Drug Type
7.2.4. North America Premenstrual Syndrome Treatment Market, By Type
7.2.5. North America Premenstrual Syndrome Treatment Market, By Distribution Channel

7.3. Europe

7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country

7.3.2.1. Germany

7.3.2.1.1. Germany Premenstrual Syndrome Treatment Market, By Drug Type
7.3.2.1.2. Germany Premenstrual Syndrome Treatment Market, By Type
7.3.2.1.3. Germany Premenstrual Syndrome Treatment Market, By Distribution Channel

7.3.2.2. France

7.3.2.2.1. France Premenstrual Syndrome Treatment Market, By Drug Type
7.3.2.2.2. France Premenstrual Syndrome Treatment Market, By Type
7.3.2.2.3. France Premenstrual Syndrome Treatment Market, By Distribution Channel

7.3.2.3. Uk

7.3.2.3.1. Uk Premenstrual Syndrome Treatment Market, By Drug Type
7.3.2.3.2. Uk Premenstrual Syndrome Treatment Market, By Type
7.3.2.3.3. Uk Premenstrual Syndrome Treatment Market, By Distribution Channel

7.3.2.4. Italy

7.3.2.4.1. Italy Premenstrual Syndrome Treatment Market, By Drug Type
7.3.2.4.2. Italy Premenstrual Syndrome Treatment Market, By Type
7.3.2.4.3. Italy Premenstrual Syndrome Treatment Market, By Distribution Channel

7.3.2.5. Spain

7.3.2.5.1. Spain Premenstrual Syndrome Treatment Market, By Drug Type
7.3.2.5.2. Spain Premenstrual Syndrome Treatment Market, By Type
7.3.2.5.3. Spain Premenstrual Syndrome Treatment Market, By Distribution Channel

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe Premenstrual Syndrome Treatment Market, By Drug Type
7.3.2.6.2. Rest of Europe Premenstrual Syndrome Treatment Market, By Type
7.3.2.6.3. Rest of Europe Premenstrual Syndrome Treatment Market, By Distribution Channel

7.3.3. Europe Market Size And Forecast, By Drug Type
7.3.4. Europe Premenstrual Syndrome Treatment Market, By Type
7.3.5. Europe Premenstrual Syndrome Treatment Market, By Distribution Channel

7.4. Asia-Pacific

7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country

7.4.2.1. Japan

7.4.2.1.1. Japan Premenstrual Syndrome Treatment Market, By Drug Type
7.4.2.1.2. Japan Premenstrual Syndrome Treatment Market, By Type
7.4.2.1.3. Japan Premenstrual Syndrome Treatment Market, By Distribution Channel

7.4.2.2. China

7.4.2.2.1. China Premenstrual Syndrome Treatment Market, By Drug Type
7.4.2.2.2. China Premenstrual Syndrome Treatment Market, By Type
7.4.2.2.3. China Premenstrual Syndrome Treatment Market, By Distribution Channel

7.4.2.3. Australia

7.4.2.3.1. Australia Premenstrual Syndrome Treatment Market, By Drug Type
7.4.2.3.2. Australia Premenstrual Syndrome Treatment Market, By Type
7.4.2.3.3. Australia Premenstrual Syndrome Treatment Market, By Distribution Channel

7.4.2.4. India

7.4.2.4.1. India Premenstrual Syndrome Treatment Market, By Drug Type
7.4.2.4.2. India Premenstrual Syndrome Treatment Market, By Type
7.4.2.4.3. India Premenstrual Syndrome Treatment Market, By Distribution Channel

7.4.2.5. South Korea

7.4.2.5.1. South Korea Premenstrual Syndrome Treatment Market, By Drug Type
7.4.2.5.2. South Korea Premenstrual Syndrome Treatment Market, By Type
7.4.2.5.3. South Korea Premenstrual Syndrome Treatment Market, By Distribution Channel

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Drug Type
7.4.2.6.2. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Type
7.4.2.6.3. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel

7.4.3. Asia-Pacific Market Size And Forecast, By Drug Type
7.4.4. Asia-Pacific Premenstrual Syndrome Treatment Market, By Type
7.4.5. Asia-Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel

7.5. Lamea

7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country

7.5.2.1. Brazil

7.5.2.1.1. Brazil Premenstrual Syndrome Treatment Market, By Drug Type
7.5.2.1.2. Brazil Premenstrual Syndrome Treatment Market, By Type
7.5.2.1.3. Brazil Premenstrual Syndrome Treatment Market, By Distribution Channel

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia Premenstrual Syndrome Treatment Market, By Drug Type
7.5.2.2.2. Saudi Arabia Premenstrual Syndrome Treatment Market, By Type
7.5.2.2.3. Saudi Arabia Premenstrual Syndrome Treatment Market, By Distribution Channel

7.5.2.3. South Africa

7.5.2.3.1. South Africa Premenstrual Syndrome Treatment Market, By Drug Type
7.5.2.3.2. South Africa Premenstrual Syndrome Treatment Market, By Type
7.5.2.3.3. South Africa Premenstrual Syndrome Treatment Market, By Distribution Channel

7.5.2.4. Rest of Lamea

7.5.2.4.1. Rest of Lamea Premenstrual Syndrome Treatment Market, By Drug Type
7.5.2.4.2. Rest of Lamea Premenstrual Syndrome Treatment Market, By Type
7.5.2.4.3. Rest of Lamea Premenstrual Syndrome Treatment Market, By Distribution Channel

7.5.3. Lamea Market Size And Forecast, By Drug Type
7.5.4. Lamea Premenstrual Syndrome Treatment Market, By Type
7.5.5. Lamea Premenstrual Syndrome Treatment Market, By Distribution Channel

Chapter 8: Company Profiles

8.1. Abbvie Inc.

8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance

8.2. Astrazeneca Plc

8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.2.6. Key Strategic Moves And Developments

8.3. Basf Corporation

8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance

8.4. Bayer Ag.

8.4.1. Company Overview
8.4.2. Operating Business Segments
8.4.3. Product Portfolio
8.4.4. Business Performance

8.5. Dr. Reddy’S Laboratories Ltd

8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance

8.6. Eli Lilly And Company.

8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance

8.7. Glaxosmithkline Plc.

8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance

8.8. H. Lundbeck A/S

8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance

8.9. Pfizer Inc.

8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance

8.10. Shionogi Inc.

8.10.1. Company Overview
8.10.2. Operating Business Segments
8.10.3. Product Portfolio
8.10.4. Business Performance



List of Figures



Figure 01. Top Investment Pockets
Figure 02. Top Player Positioning, 2018
Figure 03. Global Premenstrual Syndrome Treatment Market Segmentation
Figure 04. Impact Analysis
Figure 05. Comparative Analysis of Analgesics Market, By Country, 2018 & 2026 ($Million)
Figure 06. Comparative Analysis of Antidepressants Market, By Country, 2018 & 2026 ($Million)
Figure 07. Comparative Analysis of Oral Contraceptives & Ovarian Suppression Agents Market, By Country, 2018 & 2026 ($Million)
Figure 08. Comparative Analysis of Others Market, By Country, 2018 & 2026 ($Million)
Figure 09. Comparative Analysis of Prescription Premenstrual Syndrome Treatment Market, By Country, 2018 & 2026 ($Million)
Figure 10. Comparative Analysis of Otc Premenstrual Syndrome Treatment Market, By Country, 2018 & 2026 ($Million)
Figure 11. Comparative Analysis of Premenstrual Syndrome Treatment Market For Hospitals Pharmacies, By Country, 2018 & 2026 ($Million)
Figure 12. Comparative Analysis of Premenstrual Syndrome Treatment Market For Drug Stores & Retail Pharmacies, By Country, 2018 & 2026 ($Million)
Figure 13. Comparative Analysis of Premenstrual Syndrome Treatment Market For Online Pharmacies, By Country, 2018 & 2026 ($Million)
Figure 14. U.S. Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 15. Canada Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 16. Mexico Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 17. Germany Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 18. France Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 19. Uk Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 20. Italy Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 21. Spain Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 22. Rest of Europe Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 23. Japan Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 24. China Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 25. Australia Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 26. India Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 27. South Korea Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 28. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 29. Brazil Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 30. Saudi Arabia Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 31. South Africa Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 32. Rest of Lamea Premenstrual Syndrome Treatment Market, 2018–2026 ($Million)
Figure 33. Abbvie: Net Sales, 2016–2018 ($Million)
Figure 34. Abbvie: Revenue Share By Region, 2018(%)
Figure 35. Astrazeneca: Net Sales, 2016–2018 ($Million)
Figure 36. Astrazeneca: Revenue Share By Region, 2018(%)
Figure 37. Basf: Net Sales, 2016–2018 ($Million)
Figure 38. Basf: Revenue Share By Segment, 2018(%)
Figure 39. Basf: Revenue Share By Region, 2018(%)
Figure 40. Bayer: Net Sales, 2016–2018 ($Million)
Figure 41. Bayer.: Revenue Share By Segment, 2018 (%)
Figure 42. Bayer.: Revenue Share By Region, 2018(%)
Figure 43. Dr. Reddy’S: Net Sales, 2016–2018 ($Million)
Figure 44. Dr. Reddy’S: Revenue Share By Segment, 2018 (%)
Figure 45. Dr. Reddy’S: Revenue Share By Region, 2018(%)
Figure 46. Lilly: Net Sales, 2016–2018 ($Million)
Figure 47. Lilly: Revenue Share By Segment, 2018 (%)
Figure 48. Lilly: Revenue Share By Region, 2018(%)
Figure 49. Gsk: Net Sales, 2016–2018 ($Million)
Figure 50. Gsk: Revenue Share By Segment, 2018(%)
Figure 51. Gsk: Revenue Share By Region, 2018(%)
Figure 52. Lundbeck: Net Sales, 2016–2018 ($Million)
Figure 53. Lundbeck: Revenue Share By Segment, 2018 (%)
Figure 54. Lundbeck: Revenue Share By Region, 2018(%)
Figure 55. Pfizer: Net Sales, 2016–2018 ($Million)
Figure 56. Pfizer: Revenue Share By Segment, 2018 (%)
Figure 57. Pfizer: Revenue Share By Region, 2018(%)
Figure 58. Shionogi: Net Sales, 2016–2018 ($Million)
Figure 59. Shionogi: Revenue Share By Region, 2018(%)
Figure 60. Sanofi: Revenue Share By Segment, 2018 (%)
Figure 61. Sanofi: Revenue Share By Region, 2018(%)

 

List of Tables



Table 01. Global Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026 ($Million)
Table 02. Analgesics Market, By Region, 2018–2026 ($Million)
Table 03. Antidepressants Market, By Region, 2018–2026 ($Million)
Table 04. Oral Contraceptives & Ovarian Suppression Agents Market, By Region, 2018–2026 ($Million)
Table 05. Others Market, By Region, 2018–2026 ($Million)
Table 06. Global Premenstrual Syndrome Treatment Market, By Type, 2018–2026 ($Million)
Table 07. Prescription Premenstrual Syndrome Treatment Market, By Region, 2018–2026 ($Million)
Table 08. Otc Premenstrual Syndrome Treatment Market, By Region, 2018–2026 ($Million)
Table 09. Global Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026 ($Million)
Table 10. Premenstrual Syndrome Treatment Market For Hospitals Pharmacies, By Region, 2018–2026 ($Million)
Table 11. Premenstrual Syndrome Treatment Market For Drug Stores & Retail Pharmacies, By Region, 2018–2026 ($Million)
Table 12. Premenstrual Syndrome Treatment Market For Online Pharmacies, By Region, 2018–2026 ($Million)
Table 13. Premenstrual Syndrome Treatment Market Revenue, By Region, 2018–2026 ($Million)
Table 14. North America Premenstrual Syndrome Treatment Market, By Country, 2018–2026 ($Million)
Table 15. U.S. Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 16. U.S. Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 17. U.S. Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 18. Canada Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 19. Canada Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 20. Canada Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 21. Mexico Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 22. Mexico Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 23. Mexico Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 24. North America Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 25. North America Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 26. North America Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 27. Europe Premenstrual Syndrome Treatment Market, By Country, 2018–2026 ($Million)
Table 28. Germany Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 29. Germany Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 30. Germany Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 31. France Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 32. France Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 33. France Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 34. Uk Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 35. Uk Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 36. Uk Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 37. Italy Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 38. Italy Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 39. Italy Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 40. Spain Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 41. Spain Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 42. Spain Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 43. Rest of Europe Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 44. Rest of Europe Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 45. Rest of Europe Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 46. Europe Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 47. Europe Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 48. Europe Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 49. Asia-Pacific Premenstrual Syndrome Treatment Market, By Country, 2018–2026 ($Million)
Table 50. Japan Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 51. Japan Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 52. Japan Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 53. China Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 54. China Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 55. China Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 56. Australia Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 57. Australia Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 58. Australia Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 59. India Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 60. India Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 61. India Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 62. South Korea Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 63. South Korea Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 64. South Korea Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 65. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 66. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 67. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 68. Asia-Pacific Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 69. Asia-Pacific Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 70. Asia-Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 71. Lamea Premenstrual Syndrome Treatment Market, By Country, 2018–2026 ($Million)
Table 72. Brazil Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 73. Brazil Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 74. Brazil Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 75. Saudi Arabia Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 76. Saudi Arabia Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 77. Saudi Arabia Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 78. South Africa Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 79. South Afria Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 80. South Africa Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 81. Rest of Lamea Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 82. Rest of Lamea Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 83. Rest of Lamea Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 84. Lamea Premenstrual Syndrome Treatment Market, By Drug Type, 2018–2026
Table 85. Lamea Premenstrual Syndrome Treatment Market, By Type, 2018–2026
Table 86. Lamea Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018–2026
Table 87. Abbvie: Company Snapshot
Table 88. Abbvie: Operating Business Segments
Table 89. Abbvie: Product Portfolio
Table 90. Astrazeneca: Company Snapshot
Table 91. Astrazeneca: Operating Business Segments
Table 92. Astrazeneca: Product Portfolio
Table 93. Basf: Company Snapshot
Table 94. Basf: Operating Segments
Table 95. Basf: Product Portfolio
Table 96. Bayer.: Company Snapshot
Table 97. Bayer.: Operating Segments
Table 98. Bayer.: Product Portfolio
Table 99. Dr. Reddy’S: Company Snapshot
Table 100. Dr. Reddy’S: Operating Business Segments
Table 101. Dr. Reddy’S: Product Portfolio
Table 102. Lilly: Company Snapshot
Table 103. Lilly: Operating Segments
Table 104. Lilly: Product Portfolio
Table 105. Gsk: Company Snapshot
Table 106. Gsk: Operating Business Segments
Table 107. Gsk: Product Portfolio
Table 108. Lundbeck: Company Snapshot
Table 109. Lundbeck: Operating Business Segments
Table 110. Lundbeck: Product Portfolio
Table 111. Pfizer: Company Snapshot
Table 112. Pfizer: Operating Segments
Table 113. Pfizer: Product Portfolio
Table 114. Shionogi: Company Snapshot
Table 115. Shionogi: Operating Business Segments
Table 116. Shionogi: Product Portfolio